Literature DB >> 3402582

Pneumococcal bacteremia in cancer patients.

V Richard1, F Meunier, P Van der Auwera, P Dejace, D Daneau, J Klastersky.   

Abstract

Twenty-eight episodes of Streptococcus pneumoniae bacteremia occurring in 27 cancer patients hospitalized in the Institut Jules Bordet between July 1979 and April 1985 were reviewed. Ten patients had hematological malignancies and 17 had solid tumors (in 7 cases, of the lung). Forty-four per cent of the patients were neutropenic (less than 1000/microliters) and 36% of the patients were in septic shock. In 36% of the patients no clinical source of S. pneumoniae bacteremia could be found. Seventy-nine (21% patients) received empirical antibiotic treatment containing a beta-lactam. Two patients who did not receive any empirical treatment died within 12 hours. Overall, 11/27 patients died within the first week, and 8/27 died within the first three days. Mortality in neutropenic patients was not different from that in non-neutropenic patients. In comparison with a similar study performed previously in our institution, there was no difference in incidence, type of patient, source of bacteremia, or mortality.

Entities:  

Mesh:

Year:  1988        PMID: 3402582     DOI: 10.1007/bf00144760

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

1.  PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.

Authors:  R AUSTRIAN; J GOLD
Journal:  Ann Intern Med       Date:  1964-05       Impact factor: 25.391

2.  Update: pneumococcal polysaccharide vaccine usage--United States. Recommendations of the Immunization Practices Advisory Committee.

Authors: 
Journal:  Ann Intern Med       Date:  1984-09       Impact factor: 25.391

3.  Aetiology and outcome of severe community-acquired pneumonia.

Authors:  M A Woodhead; J T Macfarlane; F G Rodgers; A Laverick; R Pilkington; A D Macrae
Journal:  J Infect       Date:  1985-05       Impact factor: 6.072

4.  Increasing incidence of Gram-positive sepsis in cancer patients.

Authors:  P A Pizzo; S Ladisch; R M Simon; F Gill; A S Levine
Journal:  Med Pediatr Oncol       Date:  1978

Review 5.  Rarity of failure of penicillin prophylaxis to prevent postsplenectomy sepsis.

Authors:  M H Zarrabi; F Rosner
Journal:  Arch Intern Med       Date:  1986-06

6.  Severe pneumococcal infection in patients with neoplastic disease.

Authors:  M Y Chou; A E Brown; A Blevins; D Armstrong
Journal:  Cancer       Date:  1983-04-15       Impact factor: 6.860

7.  Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy.

Authors:  D J Winston; D V Dudnick; M Chapin; W G Ho; R P Gale; W J Martin
Journal:  Arch Intern Med       Date:  1983-01

8.  Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma.

Authors:  J Klastersky; P Mommen; F Cantraine; A Safary
Journal:  Eur J Cancer Clin Oncol       Date:  1986-07

9.  Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

Authors:  J C Wade; S C Schimpff; K A Newman; P H Wiernik
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

Review 10.  Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention.

Authors:  R Austrian
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr
View more
  1 in total

1.  Fluoroquinolone treatment as a protective factor for 10-day mortality in Streptococcus pneumoniae bacteremia in cancer patients.

Authors:  Naihma Salum Fontana; Karim Yaqub Ibrahim; P R Bonazzi; F Rossi; S C G Almeida; F M Tengan; M C C Brandileone; E Abdala
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.